Dye-guided lymph node biopsy for vulvar cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vulvar cancer that is either larger than 4 cm, in multiple spots, or has come back after previous treatment.
- You have not had radiation therapy to your vulva or groin area before.
- You have not had lymph node surgery in your groin area before.
- You are not allergic to the dye ICG (indocyanine green) or iodine.
- You are not currently being treated for another cancer, and your vulvar cancer has not spread to other parts of your body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
This trial tests a dye called ICG to find the first lymph nodes that might have cancer cells. It is for women with early-stage vulvar cancer that has not spread to the lymph nodes.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests a new way to find the sentinel lymph node (the first lymph node cancer might spread to) using a special augmented-reality camera and a dye called ICG. It's for women with breast cancer who are having surgery to check their lymph nodes.
Hear when a new Vulva Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.